SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Bank of New York/ADR Division – ‘F-6EF’ on 11/6/14 re: Prana Biotechnology Ltd – EX-4

On:  Thursday, 11/6/14, at 10:09am ET   ·   Effective:  11/6/14   ·   Accession #:  1019155-14-389   ·   File #:  333-199907

Previous ‘F-6EF’:  ‘F-6EF’ on 11/3/14   ·   Next:  ‘F-6EF’ on 11/19/14   ·   Latest:  ‘F-6EF’ on 5/2/24   ·   6 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

11/06/14  Bank of New York/ADR Division     F-6EF      11/06/14    4:240K Prana Biotechnology Ltd           Emmet Marvin & Mart… LLP

Registration of Depositary Shares Evidenced by American Depositary Receipts (Effective Immediately)   —   Form F-6
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: F-6EF       Form F-6                                            HTML     33K 
 2: EX-1        Form of Deposit Agreement                           HTML    156K 
 3: EX-4        Opinion of Depositary's Counsel                     HTML     10K 
 4: EX-5        Rule 466 Certification                              HTML      6K 


EX-4   —   Opinion of Depositary’s Counsel


This exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



Writer’s Direct Dial

 

EXHIBIT 4

 

Emmet, Marvin & Martin, LLP

Counsellors at Law

_____

120 Broadway

New York, New York 10271

_____

(212) 238-3000

(212) 653-1760

_____

Fax: (212) 238-3100

Fax: (212) 653-1730

http://www.emmetmarvin.com

177 Madison Avenue

Morristown, New Jersey 07960

(973) 538-5600

Fax: (973) 538-6448

 

November 6, 2014

 

The Bank of New York Mellon,

as Depositary

101 Barclay Street

New York, New York, 10286

 

Re: American Depositary Shares representing Ordinary Shares of Prana Biotechnology Limited

Ladies and Gentlemen:

We refer to the registration statement to be filed on Form F-6 under the Securities Act of 1933 (the "Registration Statement") by the legal entity created by the agreement (the "Deposit Agreement") for issuance of American Depositary Shares ("ADSs"), which may be evidenced by American Depositary Receipts ("ADRs"), representing ordinary shares of Prana Biotechnology Limited, for which you propose to act as Depositary.

 

We are of the opinion that the ADSs covered by the Registration Statement, when issued in accordance with the terms of the Deposit Agreement, will, when sold, be legally issued and will entitle the holders thereof to the rights specified in the Deposit Agreement and the ADRs.

This opinion may be used by you as an exhibit to the Registration Statement.

Very truly yours,

/s/ EMMET, MARVIN & MARTIN, LLP

EMMET, MARVIN & MARTIN, LLP

 


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘F-6EF’ Filing    Date    Other Filings
Filed on / Effective on:11/6/14F-6 POS
 List all Filings


6 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

10/02/23  Alterity Therapeutics Ltd.        F-3                    4:425K                                   MDM Corp Elec Fi… Inc/FA
12/23/20  Alterity Therapeutics Ltd.        F-3                    3:445K                                   EdgarAgents LLC/FA
12/02/20  Alterity Therapeutics Ltd.        S-8        12/02/20    4:102K                                   EdgarAgents LLC/FA
11/13/20  Alterity Therapeutics Ltd.        F-3                    4:492K                                   EdgarAgents LLC/FA
10/05/20  Alterity Therapeutics Ltd.        F-3                    3:255K                                   EdgarAgents LLC/FA
 9/23/20  Alterity Therapeutics Ltd.        S-8         9/23/20    3:73K                                    EdgarAgents LLC/FA
Top
Filing Submission 0001019155-14-000389   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sun., May 12, 12:08:08.1am ET